{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:20:03Z","timestamp":1790497203642,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,11,30]],"date-time":"2013-11-30T00:00:00Z","timestamp":1385769600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s11060-013-1280-6","type":"journal-article","created":{"date-parts":[[2013,11,29]],"date-time":"2013-11-29T09:55:31Z","timestamp":1385718931000},"page":"261-266","source":"Crossref","is-referenced-by-count":21,"title":["Retrospective evaluation of the outcomes of children with diffuse intrinsic pontine glioma treated with radiochemotherapy and valproic acid in a single center"],"prefix":"10.1007","volume":"116","author":[{"given":"Francisco Helder Cavalcante","family":"Felix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlandira Leite","family":"de Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine Martins","family":"da Trindade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia Mendon\u00e7a","family":"Trompieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juvenia Bezerra","family":"Fontenele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,30]]},"reference":[{"issue":"2","key":"1280_CR1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3171\/jns.1987.66.2.0227","volume":"66","author":"RD Jenkin","year":"1987","unstructured":"Jenkin RD, Boesel C, Ertel I et al (1987) Brain-stem tumors in childhood: a prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. A report of the Children\u2019s Cancer Study Group. J Neurosurg 66(2):227\u2013233","journal-title":"J Neurosurg"},{"key":"1280_CR2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1470-2045(06)70615-5","volume":"7","author":"D Hargrave","year":"2006","unstructured":"Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7:241\u2013248","journal-title":"Lancet Oncol"},{"issue":"1","key":"1280_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.spen.2012.02.010","volume":"19","author":"EM Wells","year":"2012","unstructured":"Wells EM, Gaillard WD, Packer RJ (2012) Pediatric brain tumors and epilepsy. Semin Pediatr Neurol 19(1):3\u20138","journal-title":"Semin Pediatr Neurol"},{"issue":"2","key":"1280_CR4","first-page":"CD004424","volume":"16","author":"I Tremont-Lukats","year":"2008","unstructured":"Tremont-Lukats I, Ratilal B, Armstrong T et al (2008) Antiepileptic drugs for preventing seizures in people with brain tumors. Cochrane Database Syst Rev 16(2):CD004424","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"1280_CR5","doi-asserted-by":"crossref","first-page":"e375","DOI":"10.1016\/S1470-2045(12)70266-8","volume":"13","author":"M Weller","year":"2012","unstructured":"Weller M, Stupp R, Wick W (2012) Epilepsy meets cancer: when, why, and what to do about it? Lancet Oncol 13(9):e375\u2013e382","journal-title":"Lancet Oncol"},{"issue":"11","key":"1280_CR6","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.33588\/rn.2811.98336","volume":"28","author":"M Kawasaki","year":"1999","unstructured":"Kawasaki M, Hern\u00e1ndez-Fustes OJ, Machado S, Aguiar LR, Mattar F, Panfilio CB, Hern\u00e1ndez-Cossio O (1999) Epilepsia y tumor cerebral. Rev Neurol 28(11):1047\u20131049","journal-title":"Rev Neurol"},{"issue":"2","key":"1280_CR7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00381-012-1997-0","volume":"29","author":"FH Felix","year":"2013","unstructured":"Felix FH, de Araujo OL, da Trindade KM et al (2013) Survival of children with malignant brain tumors receiving valproate: a retrospective study. Childs Nerv Syst 29(2):195\u2013197","journal-title":"Childs Nerv Syst"},{"key":"1280_CR8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3109\/08880018.2011.563774","volume":"28","author":"FH Felix","year":"2011","unstructured":"Felix FH, Trompieri NM, de Araujo OL, da Trindade KM, Fontenele JB (2011) Potential role for valproate in the treatment of high-risk brain tumors of childhood-results from a retrospective observational cohort study. Pediatr Hematol Oncol 28:556\u2013570","journal-title":"Pediatr Hematol Oncol"},{"issue":"5","key":"1280_CR9","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1200\/JCO.1993.11.5.850","volume":"11","author":"RJ Packer","year":"1993","unstructured":"Packer RJ, Lange B, Ater J et al (1993) Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol 11(5):850\u2013856","journal-title":"J Clin Oncol"},{"issue":"7","key":"1280_CR10","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","volume":"8","author":"DR Macdonald","year":"1990","unstructured":"Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8(7):1277\u20131280","journal-title":"J Clin Oncol"},{"issue":"2","key":"1280_CR11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11060-011-0681-7","volume":"106","author":"A Chassot","year":"2012","unstructured":"Chassot A, Canale S, Varlet P et al (2012) Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. J Neurooncol 106(2):399\u2013407","journal-title":"J Neurooncol"},{"issue":"6","key":"1280_CR12","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.ejca.2011.10.027","volume":"48","author":"AA Brandes","year":"2012","unstructured":"Brandes AA, Franceschi E, Gorlia T et al (2012) European Organisation for Research and Treatment of Cancer Brain Tumour Group. Appropriate end-points for right results in the age of antiangiogenic agents: future options for phase II trials in patients with recurrent glioblastoma. Eur J Cancer 48(6):896\u2013903","journal-title":"Eur J Cancer"},{"issue":"3","key":"1280_CR13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11060-007-9473-5","volume":"86","author":"D Hargrave","year":"2008","unstructured":"Hargrave D, Chuang N, Bouffet E (2008) Conventional MRI cannot predict survival in childhood diffuse intrinsic pontine glioma. J Neurooncol 86(3):313\u2013319","journal-title":"J Neurooncol"},{"issue":"4C","key":"1280_CR14","first-page":"2437","volume":"28","author":"A Masoudi","year":"2008","unstructured":"Masoudi A, Elopre M, Amini E et al (2008) Influence of valproic acid on outcome of high-grade gliomas in children. Anticancer Res 28(4C):2437\u20132442","journal-title":"Anticancer Res"},{"key":"1280_CR15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11060-004-2338-2","volume":"72","author":"S Oberndorfer","year":"2005","unstructured":"Oberndorfer S, Piribauer M, Marosi C et al (2005) P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J Neuro-Oncol 72:255\u2013260","journal-title":"J Neuro-Oncol"},{"issue":"3","key":"1280_CR16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11060-008-9662-x","volume":"90","author":"J Wolff","year":"2008","unstructured":"Wolff J, Kramm C, Kortmann R et al (2008) Valproic acid was well tolerated in heavily pretreated pediatric patients with high-grade glioma. J Neurooncol 90(3):309\u2013314","journal-title":"J Neurooncol"},{"key":"1280_CR17","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1212\/WNL.0b013e31822f02e1","volume":"77","author":"M Weller","year":"2011","unstructured":"Weller M, Gorlia T, Cairncross JG et al (2011) Prolonged survival with valproic acid use in the EORTC\/NCIC temozolomide trial for glioblastoma. Neurology 77:1156\u20131164","journal-title":"Neurology"},{"key":"1280_CR18","author":"GD Guthrie","year":"2012","unstructured":"Guthrie GD, Eljamel S (2012) Impact of particular antiepileptic drugs on the survival of patients with glioblastoma multiforme. J Neurosurg. doi: 10.3171\/2012.10.JNS12169","journal-title":"J Neurosurg"},{"issue":"3","key":"1280_CR19","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ijrobp.2013.02.012","volume":"86","author":"CA Barker","year":"2013","unstructured":"Barker CA, Bishop AJ, Chang M, Beal K, Chan TA (2013) Valproic acid use during radiation therapy for glioblastoma associated with improved survival. Int J Radiat Oncol Biol Phys 86(3):504\u2013509","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1280_CR20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ctrv.2007.11.003","volume":"34","author":"A Duenas-Gonzalez","year":"2008","unstructured":"Duenas-Gonzalez A, Candelaria M, Perez-Plascencia C et al (2008) Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors. Cancer Treat Rev 34(3):206\u2013222","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"1280_CR21","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1124\/mol.65.3.520","volume":"65","author":"M Michaelis","year":"2004","unstructured":"Michaelis M, Michaelis UR, Fleming I et al (2004) Valproic acid inhibits angiogenesis in vitro and in vivo. Mol Pharmacol 65(3):520\u2013527","journal-title":"Mol Pharmacol"},{"issue":"1","key":"1280_CR22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11060-012-0871-y","volume":"109","author":"Y Chen","year":"2012","unstructured":"Chen Y, Tsai YH, Tseng SH (2012) Valproic acid affected the survival and invasiveness of human glioma cells through diverse mechanisms. J Neurooncol 109(1):23\u201333","journal-title":"J Neurooncol"},{"issue":"1","key":"1280_CR23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11060-011-0725-z","volume":"107","author":"KA Nifterik Van","year":"2012","unstructured":"Van Nifterik KA, Van den Berg J, Slotman BJ, Lafleur MV, Sminia P, Stalpers LJ (2012) Valproic acid sensitizes human glioma cells for temozolomide and \u03b3-radiation. J Neurooncol 107(1):61\u201367","journal-title":"J Neurooncol"},{"issue":"30","key":"1280_CR24","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1200\/JCO.2011.35.5677","volume":"29","author":"BS Paugh","year":"2011","unstructured":"Paugh BS, Broniscer A, Qu C, Miller CP, Zhang J, Tatevossian RG, Olson JM, Geyer JR, Chi SN, da Silva NS, Onar-Thomas A, Baker JN, Gajjar A, Ellison DW, Baker SJ (2011) Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J Clin Oncol 29(30):3999\u20134006","journal-title":"J Clin Oncol"},{"issue":"3","key":"1280_CR25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ng.1102","volume":"44","author":"G Wu","year":"2012","unstructured":"Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J, Qu C, Ding L, Huether R, Parker M, Zhang J, Gajjar A, Dyer MA, Mullighan CG, Gilbertson RJ, Mardis ER, Wilson RK, Downing JR, Ellison DW, Zhang J (2012) Baker SJ; St. Jude Children\u2019s Research Hospital\u2013Washington University Pediatric Cancer Genome Project. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44(3):251\u2013253","journal-title":"Nat Genet"},{"issue":"9","key":"1280_CR26","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/pbc.24541","volume":"60","author":"TR Hummel","year":"2013","unstructured":"Hummel TR, Wagner L, Ahern C, Fouladi M, Reid JM, McGovern RM, Ames MM, Gilbertson RJ, Horton T, Ingle AM, Weigel B, Blaney SM (2013) A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a children\u2019s oncology group phase 1 consortium study. Pediatr Blood Cancer 60(9):1452\u20131457","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"1280_CR27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1158\/1078-0432.CCR-10-0738","volume":"17","author":"JM Su","year":"2011","unstructured":"Su JM, Li XN, Thompson P et al (2011) Phase 1 study of valproic acid in pediatric patients with refractory solid or CNS tumors: a children\u2019s oncology group report. Clin Cancer Res 17(3):589\u2013597","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1280_CR28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1200\/JCO.1992.10.2.249","volume":"10","author":"HS Friedman","year":"1992","unstructured":"Friedman HS, Krischer JP, Burger P et al (1992) Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study. J Clin Oncol 10(2):249\u2013256","journal-title":"J Clin Oncol"},{"issue":"1","key":"1280_CR29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10456-009-9134-8","volume":"12","author":"P Mabeta","year":"2009","unstructured":"Mabeta P, Pepper MS (2009) A comparative study on the anti-angiogenic effects of DNA-damaging and cytoskeletal-disrupting agents. Angiogenesis 12(1):81\u201390","journal-title":"Angiogenesis"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-013-1280-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-013-1280-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-013-1280-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:28:12Z","timestamp":1746059292000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-013-1280-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,30]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["1280"],"URL":"https:\/\/doi.org\/10.1007\/s11060-013-1280-6","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,30]]}}}